Related expertise

On November 29, 2018, Canopy Growth Corporation and MediPharm Labs Inc., a wholly owned subsidiary of MediPharm Labs Corp., entered into a strategic supply agreement. Under the 18-month agreement, MediPharm will supply up to 900kg of cannabis extract for sale to Canopy Growth and its subsidiaries. Canopy Growth has committed to purchasing a minimum of 450kg with an option to purchase an additional 450kg.

Cassels Brock acted for Canopy Growth with a team that included Luke Woolford and Jonathan Sherman (Business and Cannabis).